Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G, Detheux M, Parmentier M, Durinx C, Lambeir AM, Neyts J, Liekens S, Maudgal PC, Billiau A, Van Damme J.
Proost P, et al. Among authors: parmentier m.
Blood. 2001 Dec 15;98(13):3554-61. doi: 10.1182/blood.v98.13.3554.
Blood. 2001.
PMID: 11739156
Free article.